Healio (10/20, Gramigna) reports “flexible assertive community treatment (FACT)…a Dutch model of community-based mental healthcare that provides flexible, multidisciplinary support to people with severe mental illness,” appears to be “more effective than other models for individuals with severe mental illness,” investigators concluded in a large study that included data on “887 individuals in the CMHT-FACT group, 887 in the matched CMHT group, 130 in the ACT-FACT group and 130 in the matched ACT group.” The findings were published online Oct. 19 in The Lancet Psychiatry.

Related Links:

— “Community treatment model effective for individuals with severe mental illness “Joe Gramigna, Healio, October 20, 2020

Modern Healthcare (10/19, Bannow, Subscription Publication) reports “all of the health systems that responded to a recent” Kaufman Hall survey “expect it will be at least 2022 before their operations return to anything resembling a pre-pandemic ‘normal.’” The survey, conducted in August, “included 64 mostly hospital and health system respondents,” of which, “nearly three-quarters of respondents said they were moderately or extremely concerned about the financial viability of their organizations in the absence of an effective COVID-19 vaccine or treatment.” One-third “said they experienced year-over-year operating margin declines in excess of 100% between the second quarter of 2019 and the second quarter of 2020.”

Related Links:

— “Pre-pandemic ‘normal’ not expected until 2022, hospital execs say “Tara Bannow, Modern healthcare, October 19, 2020

MedPage Today (10/19, George) reports the narcolepsy medications “modafinil (Provigil) and armodafinil (Nuvigil) were both associated with major congenital malformations,” investigators concluded in “a post-marketing report.” That report revealed that “of 102 prospective live births in the U.S. Provigil/Nuvigil Pregnancy Registry, 13% had major congenital malformations, considerably above the prevalence of about 3% in the general population.” The findings were published online in a research letter in JAMA Internal Medicine.

Related Links:

— MedPage Today (requires login and subscription)

Medscape (10/19, Greb, Subscription Publication) reports researchers found “insomnia with objective short sleep duration is associated with a significantly increased risk of cognitive impairment, particularly as it relates to cardiometabolic health.” The findings were published in Sleep.

Related Links:

— Medscape (requires login and subscription)

Healio (10/19, Gramigna) reports, “Individuals with visual and/or hearing impairments were at increased risk for cognitive decline and depression,” investigators concluded after “analyzing data of 18,038 participants of a 2015 survey of the China Health and Retirement Longitudinal Study, which collected responses of adults aged 45 years or older and their spouses.” The findings of the “cross-sectional study” were published online in JAMA Network Open.

Related Links:

— “Visual, hearing impairments may increase risk for cognitive decline, depression “Joe Gramigna, Healio, October 19, 2020